Acadian Asset Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$540K Buy
+11,694
New +$421K ﹤0.01% 1426
2024
Q4
– Sell
-4,744
Closed -$274K – 2235
2024
Q3
$274K Buy
+4,744
New +$233K ﹤0.01% 1262
2021
Q3
– Sell
-27,025
Closed -$1.7M – 2061
2021
Q2
$1.7M Buy
27,025
+25,292
+1,459% +$935K 0.01% 762
2021
Q1
$47K Buy
+1,733
New +$41.7K ﹤0.01% 1841

Other funds holding ASTH

Acadian Asset Management's ASTH Position: Q2 2026 in Review

Acadian Asset Management opened a new position in Astrana Health (ASTH) in Q2 2026: 11,694 shares worth $540K. The stake represents ﹤0.01% of the portfolio and ranks #1426 among its holdings. This is a return to the name: Acadian Asset Management previously reported a position in ASTH as recently as Q3 2024.

Acadian Asset Management first reported a position in ASTH in Q1 2021 and has held it in 4 quarters since. The position peaked at $1.7M in Q2 2021. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Acadian Asset Management held 11,694 shares of Astrana Health worth $540K as of Q2 2026.
  • Astrana Health was a new Acadian Asset Management position in Q2 2026.
  • Astrana Health made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1426 holding.
  • Acadian Asset Management first reported a position in Astrana Health in Q1 2021 and has held it in 4 quarters since.
  • Acadian Asset Management's Astrana Health position peaked at $1.7M in Q2 2021.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.